Anti Phospholipid IgG Antibody, in Visit Clinic

Antiphospholipid antibody IgG is an IgG-class autoantibody directed against phospholipid-binding proteins (commonly cardiolipin and beta‑2 glycoprotein I). Persistent positivity is linked to antiphospholipid syndrome, which raises risk of arterial and venous clots and pregnancy loss. Diagnosis requires repeat positive tests at least 12 weeks apart; clinically it may lead to anticoagulation and specialist management.

An IgG antibody positive result means your blood contains IgG antibodies specific to a particular pathogen or vaccine, indicating past exposure or an immune response after vaccination. It typically reflects longer-term or memory immunity rather than active infection, but it doesn’t guarantee full protection. Interpretation depends on timing, test accuracy and clinical context; discuss results with your healthcare professional.

Antiphospholipid antibody positive means one or more antiphospholipid antibodies (anticardiolipin, lupus anticoagulant, or anti-β2‑glycoprotein I) are detected in the blood. This increases risk of blood clots, pregnancy losses and strokes; it can be transient after infection or persistent (confirmed by repeat testing ≥12 weeks). Persistent positivity with clinical events defines antiphospholipid syndrome, often managed with anticoagulation.

Typical laboratory reference ranges vary by assay, but commonly: anticardiolipin IgG (GPL units) — negative <20 GPL, low‑positive 20–40, high‑positive >40. Anti‑β2‑glycoprotein I IgG — negative <15 units, positive >15. Lupus anticoagulant is measured by functional clotting assays and reported differently. Lab cutoffs vary; interpret results clinically and repeat testing after 12 weeks.

Management depends on clinical status. Asymptomatic antibody carriers usually need no anticoagulation; consider low‑dose aspirin if high‑risk profile or other risk factors. Patients with thrombotic antiphospholipid syndrome require long‑term anticoagulation (vitamin K antagonists, target INR 2.0–3.0; higher or combined therapy for recurrent events). In pregnancy use low‑dose aspirin plus prophylactic LMWH; avoid warfarin and often avoid DOACs in high‑risk APS. Control cardiovascular risks.

An anti-IgG test detects IgG-class antibodies—either circulating in blood or bound to cells. It’s used to identify past or ongoing immune responses (for example infections or autoimmune antibodies) and, in the direct antiglobulin (Coombs) test, to detect IgG-coated red blood cells indicating immune hemolysis or transfusion reactions. Results help diagnose immune-mediated conditions and guide treatment.